Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

5.8K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

393
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
393
Non-equilibrium in the Cell01:16

Non-equilibrium in the Cell

4.9K
An important concept in studying metabolism and energy is that of chemical equilibrium. Most chemical reactions are reversible. They can proceed in both directions, releasing energy into their environment in one direction, and absorbing it from the environment in the other direction. The same is true for the chemical reactions involved in cell metabolism, such as the breaking down and building up of proteins into and from individual amino acids, respectively. Reactants within a closed system...
4.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the road to fully automated insulin delivery: A systematic review of meal announcement free algorithms.

PLOS digital health·2026
Same author

Sex differences in glycemic outcomes: a systematic review and meta-analysis of diabetes treatments.

BMJ open diabetes research & care·2026
Same author

Research Code Sharing in Support of Gold Standard Science.

Journal of diabetes science and technology·2026
Same author

Analyzing Basal Insulin Dosing as Perturbations in Compositional Glycemic Profiles for Time in Range in Type 1 Diabetes.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Explainable cluster-based learning for prediction of postprandial glycemic events and insulin dose optimization in type 1 diabetes.

PLOS digital health·2025
Same author

Including Aerobic Exercise Into Data-Based Virtual Twins for Glycemic Simulation.

Journal of diabetes science and technology·2025

Related Experiment Video

Updated: Sep 14, 2025

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
09:31

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres

Published on: November 5, 2016

7.3K

Generative artificial intelligence in diabetes healthcare.

Josep Vehi1,2, Omer Mujahid1, Aleix Beneyto1

  • 1Modeling and Intelligent Control Engineering Laboratory, Institut d'Informàtica i Aplicacions, Universitat de Girona, 17003 Girona, Spain.

Iscience
|July 24, 2025
PubMed
Summary

Generative artificial intelligence (AI) offers powerful tools for diabetes care, generating synthetic data and simulating patient dynamics. Challenges like data needs and interpretability remain key areas for future research and ethical consideration.

Keywords:
Artificial intelligenceDiabetologyHealth sciences

More Related Videos

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

1.9K
Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer
16:59

Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer

Published on: October 10, 2012

11.9K

Related Experiment Videos

Last Updated: Sep 14, 2025

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
09:31

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres

Published on: November 5, 2016

7.3K
Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

1.9K
Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer
16:59

Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer

Published on: October 10, 2012

11.9K

Area of Science:

  • Artificial Intelligence
  • Biomedical Informatics
  • Diabetes Technology

Background:

  • Generative artificial intelligence (AI) models, particularly large language models, have advanced rapidly, impacting various fields.
  • Generative AI excels at modeling, simulating, and generating high-fidelity data, addressing challenges like data scarcity and patient variability.
  • Applications in diabetes care are emerging, promising personalized solutions and improved patient outcomes.

Purpose of the Study:

  • To explore the application of deep generative models in diabetes healthcare.
  • To review key generative AI models and their use in different data types relevant to diabetes.
  • To outline the opportunities, limitations, and ethical considerations of generative AI in this domain.

Main Methods:

  • Review of current literature on deep generative models.
  • Exploration of models including variational autoencoders, generative adversarial networks, transformers, and diffusion models.
  • Application analysis across tabular, time series, image, and text data in diabetes care.

Main Results:

  • Generative AI models facilitate synthetic patient data generation and dataset augmentation.
  • These models enable simulation of glucose-insulin dynamics and development of virtual coaches and digital twins.
  • Key models discussed include VAEs, GANs, transformers, and diffusion models for diverse data types.

Conclusions:

  • Generative AI presents significant opportunities for advancing diabetes care through data synthesis and simulation.
  • Challenges such as model instability, data requirements, and interpretability need to be addressed.
  • Ethical considerations are paramount for the responsible implementation of generative AI in diabetes healthcare.